Target intelligence / Profile preview

Small proline-rich protein 1A (SPRR1A)

Target
SPRR1A
Molecular classification
Structural protein, Epidermal differentiation complex member, Precursor of the cornified envelope, Other (not an enzyme, receptor, channel, or transcription factor)
01

Overview

Small proline-rich protein 1A is a structural protein primarily involved in the formation of the cornified envelope in terminally differentiating keratinocytes, contributing to skin barrier function. It is a member of the small proline-rich protein family and is encoded in the epidermal differentiation complex on chromosome 1q21. SPRR1A acts as a precursor that is ultimately cross-linked by transglutaminase to form an insoluble layer beneath the plasma membrane. Originally a squamous cell differentiation marker, SPRR1A can be stress-inducible in non-squamous tissues such as heart and neuronal cells, where it supports cytoprotection, tissue remodeling, and regeneration after injury. SPRR1A is upregulated in various cancers and tissue injuries, and its high expression is often associated with poor prognosis, particularly in pancreatic ductal adenocarcinoma and other malignancies

Other names
Cornifin-ASPRKSPR-IA19 kDa pancornulinSmall proline-rich protein IAPancornulin
02

Mechanism of action

Not applicable, as no drugs directly target SPRR1A. Its induction results from cellular signaling pathways (e.g., the gp130 pathway) and it exerts cytoprotective and structural roles

03

Biological functions

Keratinocyte differentiationFormation of cornified envelopeCytoprotection during cellular stress and tissue injuryInvolvement in axonal outgrowth in neuronsPeptide cross-linking
04

Disease associations

Cancer (prognostic marker in breast, colon, diffuse large B-cell lymphoma, and pancreatic ductal adenocarcinoma)Inflammation (induction in injured/exposed tissues)Cardiac injury (cytoprotective mediator in cardiomyocytes during stress/injury)Other: Marker for squamous cell differentiation, expressed during tissue remodeling and regeneration after injury
05

Biomarkers

SPRR1A expression is used as a prognostic biomarker in cancers (especially squamous cell carcinoma, breast cancer, colon cancer, diffuse large B-cell lymphoma, and pancreatic ductal adenocarcinoma)Marker for squamous cell differentiation

Beyond the preview

Go deeper on Small proline-rich protein 1A (SPRR1A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Small proline-rich protein 1A (SPRR1A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call